Dupilumab Subcutaneous and Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate
Determining the interaction of Dupilumab Subcutaneous and Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: efavirenz / emtricitabine / tenofovir
Brand name: Atripla
Synonyms: Efavirenz, emtricitabine, and tenofovir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Efavirenz, lamivudine, and tenofovir
- Dupilumab Subcutaneous-Efavirenz, Lamivudine, and Tenofovir Disoproxil Fumarate
- Dupilumab Subcutaneous-Effaclor Duo
- Dupilumab Subcutaneous-Effer-K
- Dupilumab Subcutaneous-Effer-K Tablets
- Dupilumab Subcutaneous-Effervescent Potassium
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Dupixent
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Duplex T Topical
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Durachol
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Duraclon
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Duraclon injection
- Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate-Duraflu